Gilead Sciences (Foster City, CA) Successfully Completes Tender Offer For Shares Of Myogen With Over 91.3 Percent Of Shares Tendered

Published: Nov 14, 2006

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today the successful completion of its cash tender offer for all of the outstanding shares of common stock of Myogen (Nasdaq:MYOG). The offer expired as scheduled at one minute following 11:59 p.m., New York City time (midnight), on November 13, 2006.

Back to news